Slc31a1em1Bjme
Endonuclease-mediated Allele Detail
|
Symbol: |
Slc31a1em1Bjme |
Name: |
solute carrier family 31, member 1; endonuclease-mediated mutation 1, Bradley J Merrill |
MGI ID: |
MGI:6883631 |
Synonyms: |
mCtr1(C187A), mCtr1KI |
Gene: |
Slc31a1 Location: Chr4:62278964-62310006 bp, + strand Genetic Position: Chr4, 33.11 cM, cytoband C1-C2
|
Alliance: |
Slc31a1em1Bjme page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
Mutation: |
|
Nucleotide substitutions
|
|
|
Mutation details: CRISPR/Cas9 technology generated a cysteine to alanine substitution at amino acid 195 [previously residue187 (C187A)] resulting in a Cys195-oxidation-defective redox-dead Slc31a1 mutant mice. This corresponds to the human C189A.
(J:321043)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Slc31a1 Mutation: |
41 strains or lines available
|
|
Original: |
J:321043 Das A, et al., Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis. Nat Cell Biol. 2022 Jan;24(1):35-50 |
All: |
1 reference(s) |
|